Podcast

Joan Mannick on Rapamycin Longevity Series | Turning down mTOR to young levels may be good for aging

Brian Kennedy on Rapamycin Master Series | Aging is the biggest risk factor for age-related diseases

Mikhail Blagosklonny on Rapamycin Longevity Series | mTOR drives age-related diseases

Brad Stanfield on Rapamycin Longevity Series | Rapamycin, mTOR and the importance of muscle in life

Pankaj Kapahi on Rapamycin Longevity Series | There is no one size intervention that fits all

Matt Kaeberlein on Rapamycin Longevity Series | Lessons learned from 2 decades of Rapamycin research

Alan Green on Rapamycin Longevity Series | Lessons learned from over 1200 patients

Ross Pelton on Rapamycin Longevity Series | How it all began